FDA Import Refusal 1FX-6826649-3/10002/1 — BOEHRINGER INGELHEIM
The FDA refused shipment 1FX-6826649-3/10002/1 from BOEHRINGER INGELHEIM (Mexico) on Jul 21, 2026. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 118 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jul 21, 2026
- Country
- Mexico
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 118